☰

Shafiqur Rahman, Ph.D. - Publications

Affiliations: 
2007- Pharmaceutical Sciences South Dakota State University, Brookings, SD, United States 
Area:
Neuroscience, Pharmacology, Drug Addiction, Major Depressive Disorder, Chronic Pain
Website:
https://www.sdstate.edu/directory/shafiqur-rahman
Tree Info Grants Similar researchers PubMed Report error

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bell RL, Rahman S. Preface. International Review of Neurobiology. 161: xi-xii. PMID 34801176 DOI: 10.1016/S0074-7742(21)00104-5  0.184
2022 Chen G, M Ghazal M, Rahman S, Lutfy K. The impact of adolescent nicotine exposure on alcohol use during adulthood: The role of neuropeptides Int Rev Neurobiol. 161: 53-93. PMID 34801174 DOI: 10.1016/bs.irn.2021.07.006  0.245
2022 Rahman S, Bell RL. Future directions for part II: Substance use disorders in adolescence-A vision for a better future Int Rev Neurobiol. 161: 303-307. PMID 34801173 DOI: 10.1016/bs.irn.2021.09.001  0.182
2022 Tschetter KE, Callahan LB, Flynn SA, Rahman S, Beresford TP, Ronan PJ. Early life stress and susceptibility to addiction in adolescence Int Rev Neurobiol. 161: 277-302. PMID 34801172 DOI: 10.1016/bs.irn.2021.08.007  0.28
2022 Rahman S, Rahman ZI, Ronan PJ, Lutfy K, Bell RL. Adolescent opioid abuse: Role of glial and neuroimmune mechanisms Int Rev Neurobiol. 161: 147-165. PMID 34801168 DOI: 10.1016/bs.irn.2021.07.003  0.199
2021 Kumar D, Sharma A, Taliyan R, Urmera MT, Calderon OH, Heinbockel T, Rahman S, Goyal R. Orchestration of the circadian clock and its association with Alzheimer's disease: role of endocannabinoid signaling. Ageing Research Reviews. 101533. PMID 34844016 DOI: 10.1016/j.arr.2021.101533  0.627
2021 Bell RL, Rahman S. Preface. International Review of Neurobiology. 160: xiii-xx. PMID 34696881 DOI: 10.1016/S0074-7742(21)00093-3  0.184
2021 Rahman S, Bell RL. Future directions for part I: Substance use disorder in adolescence-A vision for a better future. International Review of Neurobiology. 160: 341-344. PMID 34696878 DOI: 10.1016/bs.irn.2021.08.008  0.188
2021 Hauser SR, Rodd ZA, Deehan GA, Liang T, Rahman S, Bell RL. Effects of adolescent substance use disorders on central cholinergic function. International Review of Neurobiology. 160: 175-221. PMID 34696873 DOI: 10.1016/bs.irn.2021.07.008  0.235
2021 Islam N, Rahman S. Novel Pulmonary Delivery of Antiviral Drugs for Treating COVID-19 in Patients with Parkinson's Disease. Current Drug Delivery. PMID 33797367 DOI: 10.2174/1567201818666210331121803  0.204
2020 Abbas M, Alzarea S, Papke RL, Rahman S. Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-induced Allodynia and Hyperalgesia in a Mouse Model of Inflammatory Pain. Cns & Neurological Disorders Drug Targets. PMID 33380307 DOI: 10.2174/1871527319666201230102616  0.309
2019 Abbas M, Alzarea S, Papke RL, Rahman S. The α7 nicotinic acetylcholine receptor positive allosteric modulator prevents lipopolysaccharide-induced allodynia, hyperalgesia and TNF-α in the hippocampus in mice. Pharmacological Reports : Pr. 71: 1168-1176. PMID 31655281 DOI: 10.1016/j.pharep.2019.07.001  0.286
2019 Rahman S. Preface. Progress in Molecular Biology and Translational Science. 167: xiii-xiv. PMID 31601408 DOI: 10.1016/S1877-1173(19)30180-2  0.184
2019 Rahman S, Alzarea S. Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities. Progress in Molecular Biology and Translational Science. 167: 159-178. PMID 31601403 DOI: 10.1016/bs.pmbts.2019.06.010  0.277
2019 Phelps BJ, Miller TM, Arens H, Hutchinson T, Lang KA, Muckey LM, Thompson N, Stanage S, Rahman S, Rawls SM. Preliminary Evidence from Planarians That Cotinine Establishes a Conditioned Place Preference. Neuroscience Letters. PMID 30890472 DOI: 10.1016/J.Neulet.2019.03.024  0.238
2019 Alzarea S, Rahman S. Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice. Behavioural Brain Research. 366: 19-28. PMID 30877025 DOI: 10.1016/j.bbr.2019.03.019  0.298
2018 Alotaibi G, Rahman S. Effects of glial glutamate transporter activator in formalin-induced pain behavior in mice. European Journal of Pain (London, England). PMID 30427564 DOI: 10.1002/ejp.1343  0.258
2018 Alzarea S, Rahman S. Effects of alpha-7 nicotinic allosteric modulator PNU 120596 on depressive-like behavior after lipopolysaccharide administration in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 29800595 DOI: 10.1016/j.pnpbp.2018.05.018  0.289
2017 Abbas M, Alzarea S, Papke RL, Rahman S. The α7 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal IκB and CD11b gene expression in mice. Drug Discoveries & Therapeutics. 11: 206-211. PMID 28867753 DOI: 10.5582/ddt.2017.01038  0.31
2017 Roni MA, Rahman S. Lobeline attenuates ethanol abstinence-induced depression-like behavior in mice. Alcohol (Fayetteville, N.Y.). PMID 28554528 DOI: 10.1016/j.alcohol.2017.01.015  0.291
2016 Islam N, Abbas M, Rahman S. Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy. Cns & Neurological Disorders Drug Targets. PMID 27978796 DOI: 10.2174/1871527315666161213104417  0.22
2016 Abbas M, Rahman S. Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice. European Journal of Pharmacology. 783: 85-91. PMID 27154173 DOI: 10.1016/j.ejphar.2016.05.003  0.341
2016 Bell RL, Rahman S. Preface. International Review of Neurobiology. 126: xv-xix. PMID 27055624 DOI: 10.1016/S0074-7742(16)30061-7  0.184
2016 Rahman S. Preface. Progress in Molecular Biology and Translational Science. 137: xi-xiii. PMID 26810005 DOI: 10.1016/S1877-1173(15)00253-7  0.184
2016 Rahman S, Engleman EA, Bell RL. Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism. Progress in Molecular Biology and Translational Science. 137: 183-201. PMID 26810002 DOI: 10.1016/Bs.Pmbts.2015.10.004  0.269
2016 Bell RL, Hauser SR, McClintick J, Rahman S, Edenberg HJ, Szumlinski KK, McBride WJ. Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings. Progress in Molecular Biology and Translational Science. 137: 41-85. PMID 26809998 DOI: 10.1016/Bs.Pmbts.2015.10.018  0.318
2015 Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661236 DOI: 10.1177/0271678X15616978  0.238
2015 Roni MA, Rahman S. Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice. Pharmacology, Biochemistry, and Behavior. 139: 1-6. PMID 26455278 DOI: 10.1016/j.pbb.2015.10.006  0.307
2015 Rahman S. Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction. Cns & Neurological Disorders Drug Targets. 14: 647-53. PMID 25921743  0.292
2015 Roni MA, Rahman S. The effects of lobeline on depression-like behavior and hippocampal cell proliferation following chronic stress in mice. Neuroscience Letters. 584: 7-11. PMID 25451721 DOI: 10.1016/j.neulet.2014.10.009  0.285
2014 Rahman S, Engleman EA, Bell RL. Nicotinic receptor modulation to treat alcohol and drug dependence. Frontiers in Neuroscience. 8: 426. PMID 25642160 DOI: 10.3389/Fnins.2014.00426  0.294
2014 Roni MA, Rahman S. The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice. Psychopharmacology. 231: 2989-98. PMID 24682499 DOI: 10.1007/s00213-014-3472-y  0.342
2013 Sajja RK, Rahman S. Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice. Pharmacology, Biochemistry, and Behavior. 110: 161-7. PMID 23872372 DOI: 10.1016/j.pbb.2013.07.009  0.283
2013 Sajja RK, Rahman S. Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of ΔFosB in mice. Alcohol (Fayetteville, N.Y.). 47: 299-307. PMID 23601929 DOI: 10.1016/j.alcohol.2013.02.003  0.273
2013 Rahman S. Nicotinic receptors as therapeutic targets for drug addictive disorders. Cns & Neurological Disorders Drug Targets. 12: 633-40. PMID 23574176  0.289
2013 Roni MA, Rahman S. Antidepressant-like effects of lobeline in mice: behavioral, neurochemical, and neuroendocrine evidence. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 41: 44-51. PMID 23200829 DOI: 10.1016/j.pnpbp.2012.11.011  0.37
2012 Islam N, Rahman S. Improved treatment of nicotine addiction and emerging pulmonary drug delivery. Drug Discoveries & Therapeutics. 6: 123-32. PMID 22890202  0.25
2012 Sajja RK, Rahman S. Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice. Pharmacology, Biochemistry, and Behavior. 102: 36-43. PMID 22741175  0.311
2012 Rahman S, Prendergast MA. Cholinergic receptor system as a target for treating alcohol abuse and dependence. Recent Patents On Cns Drug Discovery. 7: 145-50. PMID 22574675  0.259
2012 Rahman S. Epigenetic mechanisms: targets for treatment of alcohol dependence and drug addiction. Cns & Neurological Disorders Drug Targets. 11: 101. PMID 22483287  0.218
2011 Roni MA, Rahman S. Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice. Neuroscience Letters. 504: 237-41. PMID 21964392 DOI: 10.1016/j.neulet.2011.09.035  0.372
2011 Rahman S. Neuronal nicotinic acetylcholine receptors: emerging therapeutic targets for alcoholism. Commentary. Cns & Neurological Disorders Drug Targets. 10: 526. PMID 21631405 DOI: 10.2174/187152711796234961  0.336
2011 Rahman S. Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research. Progress in Molecular Biology and Translational Science. 98: 349-65. PMID 21199776 DOI: 10.1016/B978-0-12-385506-0.00008-9  0.304
2011 Rahman S. Preclinical research and drug development in humans. Preface. Progress in Molecular Biology and Translational Science. 98: xi-xiv. PMID 21199768 DOI: 10.1016/B978-0-12-385506-0.00016-8  0.189
2011 Sajja RK, Rahman S. Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 257-64. PMID 21111768 DOI: 10.1016/j.pnpbp.2010.11.020  0.283
2010 Sajja RK, Dwivedi C, Rahman S. Nicotinic ligands modulate ethanol-induced dopamine function in mice. Pharmacology. 86: 168-73. PMID 20714207 DOI: 10.1159/000317063  0.303
2010 Rahman S. Targeting opioid receptors: A new treatment for brain disorders. Cns & Neurological Disorders Drug Targets. 9: 128. PMID 20401980  0.245
2009 Bell RL, Eiler BJ, Cook JB, Rahman S. Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats. Alcohol (Fayetteville, N.Y.). 43: 581-92. PMID 20004336 DOI: 10.1016/J.Alcohol.2009.09.027  0.286
2008 Rahman S, López-Hernández GY, Corrigall WA, Papke RL. Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction. Cns & Neurological Disorders Drug Targets. 7: 422-41. PMID 19128201 DOI: 10.2174/187152708786927831  0.306
2008 Rahman S. Drug addiction and brain targets: from preclinical research to pharmacotherapy. Cns & Neurological Disorders Drug Targets. 7: 391-2. PMID 19128198 DOI: 10.2174/187152708786927840  0.198
2008 Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens. European Journal of Pharmacology. 601: 103-5. PMID 19000671 DOI: 10.1016/J.Ejphar.2008.10.037  0.384
2008 Rahman S, Bardo MT. Environmental enrichment increases amphetamine-induced glutamate neurotransmission in the nucleus accumbens: a neurochemical study. Brain Research. 1197: 40-6. PMID 18242591 DOI: 10.1016/j.brainres.2007.12.052  0.367
2007 Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology. 52: 755-63. PMID 17097117 DOI: 10.1016/J.Neuropharm.2006.09.012  0.352
2004 Rahman S, Zhang J, Corrigall WA. Effects of nicotine preexposure on sulpiride-induced dopamine release in the nucleus accumbens. European Journal of Pharmacology. 494: 31-4. PMID 15194448 DOI: 10.1016/j.ejphar.2004.04.044  0.269
2002 Rahman S, McBride WJ. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. Journal of Neurochemistry. 80: 646-54. PMID 11841572 DOI: 10.1046/J.0022-3042.2001.00739.X  0.359
1997 Rahman S, Neuman RS. Action of 5-hydroxytryptamine in facilitating N-methyl-D-aspartate depolarization of cortical neurones mimicked by calcimycin, cyclopiazonic acid and thapsigargin. British Journal of Pharmacology. 119: 877-84. PMID 8922735 DOI: 10.1111/j.1476-5381.1996.tb15754.x  0.753
1996 Neuman RS, Rahman S. Ca2+ mobilizing agents mimic serotonin 5-HT2A facilitation of N-methyl-D-aspartate depolarization. Behavioural Brain Research. 73: 273-5. PMID 8788517 DOI: 10.1016/0166-4328(96)00111-8  0.757
1996 Rahman S, Neuman RS. Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones. British Journal of Pharmacology. 117: 675-83. PMID 8646413 DOI: 10.1111/j.1476-5381.1996.tb15243.x  0.752
1995 Rahman S, McLean JH, Darby-King A, Paterno G, Reynolds JN, Neuman RS. Loss of cortical serotonin2A signal transduction in senescent rats: reversal following inhibition of protein kinase C. Neuroscience. 66: 891-901. PMID 7651616 DOI: 10.1016/0306-4522(95)00002-Z  0.704
1994 Rahman S, Neuman RS. Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization. Brain Research. 631: 349-51. PMID 8131066 DOI: 10.1016/0006-8993(93)91557-9  0.75
1993 Rahman S, Neuman RS. Activation of 5-HT2 receptors facilitates depolarization of neocortical neurons by N-methyl-D-aspartate. European Journal of Pharmacology. 231: 347-54. PMID 8449227 DOI: 10.1016/0014-2999(93)90109-u  0.763
1993 Rahman S, Neuman RS. Multiple mechanisms of serotonin 5-HT2 receptor desensitization. European Journal of Pharmacology. 238: 173-80. PMID 8405090 DOI: 10.1016/0014-2999(93)90845-9  0.77
Show low-probability matches.